F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer

International Journal of Colorectal Disease

Volumn 28, Issue 12, 2013, Pages 1699-1705

  Giacomobono, S ^a   Gallicchio, R ^a   Capacchione, D ^a   Nardelli, A ^b   Gattozzi, D ^c   Lettini, G ^a   Molinari, L ^a   Mainenti, P ^b   Cammarota, A ^a   Storto, G ^a  

^a REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

F 18 FDG PET CT; Colorectal cancer; Loco regional relapse; Quantitative assessment

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL SURGERY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE AGED; OVERALL SURVIVAL; PET-CT SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOACTIVITY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SURVIVAL TIME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; ENDPOINT DETERMINATION; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSITRON-EMISSION TOMOGRAPHY; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84889884838     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-013-1747-0     Document Type: Article

References (32)

1. Chua TC, Liauw W, Chu F et al (2012) Viewing metastatic colorectal cancer as a curable chronic disease. Am J Clin Oncol 35:77-80
2. Domati F, Rossi G, Benatti P et al (2011) Long-term survey of patients with curable colorectal cancer with specific reference to the quality of life. Intern Emerg Med 6:529-535
3. Jemal A, Tiwari RC, Murray T et al (2004) Cancer Statistics, 2004. CA Cancer J Clin 54:8-29
4. Bipat S, Niekel MC, Comans EF et al (2012) Imaging modalities for the staging of patients with colorectal cancer. Neth J Med 70:26-34
5. Shen YY, Liang JA, Chen YK et al (2006) Clinical impact of F-18-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan. Hepatogastroenterology 53:348-350
6. Dias AR, Nahas SC, Camargo EE et al (2007) Recent evidences of the use of F-18-fluorodeoxyglucose positron emission tomography in the management of colorectal cancer. J Surg Educ 64:114-119
7. Lu YY, Chen JH, Chien CR, et al. (2013) Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis. Int J Colorectal Dis Feb 14. [Epub ahead of print]
8. Giorgetti A, Sorace O, Pisani P et al (2000) Accuracy of qualitative and semiquantitative analysis of 18FDG positron emission tomography scans in the evaluation of primary and metastatic lesions. Clin Positron Imaging 3:182
9. Kelley RK, Van Bebber SL, Phillips KA et al (2011) Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer. J Natl Compr Canc Netw 9:13-25
10. Rockall TA, McDonald PJ (1999) Carcinoembryonic antigen: its value in the follow-up of patients with colorectal cancer. Int J Colorectal Dis 14:73-77
11. Brethauer SA, Magrino TJ, Riffenburgh RH et al (2002) Management of recurrent colorectal carcinoma. Color Dis 4:246-253. doi: 10.1046/j.1463-1318. 2002.00327.x
12. Even-Sapir E, Parag Y, Lerman H et al (2004) Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 232:815-822. doi: 10.1148/radiol.2323031065
13. Mainenti PP, Iodice D, Segreto S et al (2011) Colorectal cancer and 18FDG-PET/CT: what about adding the T to the N parameter in loco-regional staging? World J Gastroenterol 17:1427-1433
14. Wiggers T, Mannaerts GH, Marinelli AW et al (2003) Surgery for locally recurrent rectal cancer. Colorectal Dis 5:504-507
15. Kyoto Y, Momose M, Kondo C et al (2010) Ability of F-18-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations. Ann Nucl Med 24:395-401
16. Shreve PD, Anzai Y, Wahl RL (1999) Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 19:61-77
17. Quirce Pisano R, Banzo Marraco I, Jiménez-Bonilla JF et al (2008) Potential sources of diagnostic pitfall and variants in FDG-PET/CT. Rev Esp Med Nucl 27:130-159
18. 18F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging. Clin Radiol 66:366-382
19. MERCURY Study Group, Shihab OC, Taylor F, Bees N et al (2011) Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer. Brit J Surg 98:1798-1804
20. Patel UB, Taylor F, Blomqvist L et al (2011) Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol 29:3753-3760
21. Willett C, Tepper JE, Cohen A et al (1984) Local failure following curative resection of colonic adenocarcinoma. Int J Radiat Oncol Biol Phys 10:645-651
22. Pilipshen SJ, Heilweil M, Quan SH et al (1984) Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 53:1354-1362
23. Read TE, Mutch MG, Chang BW et al (2002) Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon. J Am Coll Surg 195:33-40
24. Hasegawa J, Nishimura J, Yamamoto S et al (2011) Exfoliated malignant cells at the anastomosis site in colon cancer surgery: the impact of surgical bowel occlusion and intraluminal cleaning. Int J Colorectal Dis 26:875-880
25. Petersen S, Freitag M, Hellmich G et al (1998) Anastomotic leakage: impact on local recurrence and survival in surgery of colorectal cancer. Int J Colorectal Dis 13:160-163
26. Flanagan FL, Dehdashti F, Ogunbiyi OA et al (1998) Utility of FDGPET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 227:319-323
27. Maldonado A, Sancho F, Cerdan J et al (2000) FDG-PET in the detection of recurrence in colorectal cancer based on rising CEA level. Experience in 72 patients. Clin Positron Imaging 3:170
28. Flamen P, Hoekstra OS, Homans F et al (2001) Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET). Eur J Cancer 37:862-869
29. Libutti SK, Alexander HR Jr, Choyke P et al (2001) A prospective study of 2-[F-18] fluoro-2-deoxy-d-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels. Ann Surg Oncol 8:779-786
30. Zervos EE, Badgwell BD, Burak WE Jr et al (2001) Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup. Surgery 130:636-643
31. Smeets P, Ham H, Ceelen W et al (2010) Differentiation between peri-anastomotic inflammatory changes and local recurrence following neoadjuvant radiochemotherapy surgery for colorectal cancer using visual and semiquantitative analysis of PET-CT data. Q J Nucl Med Mol Imaging 54:327-332
32. Simo M, Lomena F, Setoain J et al (2002) FDG-PET improves the management of patients with suspected recurrence of colorectal cancer. Nucl Med Commun 23:975-982